GE Healthcare

Massachusetts Life Sciences Center awards 11 companies tax incentives for 1,075 new jobs

Thursday, April 30, 2015 11:58 AM

The Massachusetts Life Sciences Center (MLSC), an investment agency that supports life sciences innovation, research, development and commercialization, has awarded $19 million in tax incentives to 11 life sciences companies. The recipients have committed to creating 1,075 new jobs in the Commonwealth in 2015.

More... »

Quest Diagnostics

Veracyte, GE collaborate to improve disease diagnosis

Wednesday, April 15, 2015 12:54 PM

Veracyte, a South San Francisco, Calif.-based molecular diagnostic company pioneering the field of molecular cytology, and GE, focused on software, advanced manufacturing, energy and healthcare, have formed a research collaboration to develop new solutions that can improve disease diagnosis. Financial and other terms have not been disclosed.

More... »


Catalent launches Quality, Product Development & Regulatory Affairs organization

Thursday, March 19, 2015 02:55 PM

Catalent Pharma Solutions, a Somerset, N.J.-based global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has formed the Quality, Product Development & Regulatory Affairs organization, established to build upon Catalent’s experience in new product development, regulatory excellence, reliable supply and quality. Sharon Johnson, senior vice president, global quality & regulatory affairs, will head up Catalent’s new organization.

More... »

Life Sciences Hub Wales launched

Thursday, July 17, 2014 12:45 PM

The Welsh government has launched the Life Sciences Hub Wales, a national and international focal point for the life sciences and healthcare sectors in Wales. The life sciences hub will be based in Cardiff Bay and will bring together academic, business, clinical, professional services and funding organizations.

More... »

ERT partners with GE Healthcare

Friday, April 11, 2014 12:04 PM

ERT, a global solution provider for high-quality patient safety and efficacy endpoint data collection, has entered into an agreement with GE Healthcare that enables ERT to introduce the QT Guard Plus Analysis System to the clinical trial industry as part of its centralized cardiac safety solutions. 

More... »

CEOi, NY Academy of Sciences to launch Global Alzheimer's Platform

Wednesday, February 26, 2014 01:21 PM

The Global CEO Initiative (CEOi) on Alzheimer's Disease and the New York Academy of Sciences have convened representatives from industry, academia, government and nonprofits to launch the development of a Global Alzheimer's Platform (GAP), designed to reduce the time and costs of Alzheimer's clinical trials, develop an infrastructure that promotes innovation and assure international collaboration.

More... »

Report: U.S. Alzheimer's imaging agent market will grow as reimbursement improves

Thursday, February 13, 2014 03:03 PM

The U.S. Alzheimer's imaging agent market will grow dramatically over the next 10 years, according to Decision Resources Group. Currently, Eli Lilly's Amyvid, launched in June 2013, is the only FDA-approved product available, but GE Healthcare, Piramal Enterprises and Navidea Biopharmaceuticalsare all poised to launch products in the U.S. in the next few years.

More... »

GE acquires assets from Thermo Fisher Scientific

Monday, January 6, 2014 03:06 PM

GE Healthcare will acquire Waltham, Mass.-based Thermo Fisher Scientific’s HyClone cell culture (sera and media), gene modulation and magnetic beads businesses for approximately $1.06 billion.

More... »

National MS Society, GE Healthcare partner

Wednesday, October 2, 2013 01:08 PM

The National Multiple Sclerosis Society is collaborating with GE Healthcare through Fast Forward, a nonprofit subsidiary of the National Multiple Sclerosis Society, to co-fund a clinical study with the GE investigational PET tracer, GE180, in patients with multiple sclerosis (MS). The clinical study, which will be enrolling patients in the U.K., is aimed to aid in physicians' understanding of whether imaging neuroinflammation in MS patients before and after treatment with natalizumab (Tysabri) can help identify which patients may respond to treatment.

More... »

Sanofi appoints two new members to executive committee

Friday, May 3, 2013 12:22 PM

Global healthcare company Sanofi is creating two new units, global commercial operations and global divisions and strategic commercial development, to replace the former global operations unit. Peter Guenter, currently senior vice president, Europe, will be appointed executive vice president of global commercial operations. Pascale Witz, currently president and CEO of medical diagnostics at GE Healthcare, will join Sanofi as executive vice president of global divisions and strategic commercial development. Both Guenter and Witz will join the executive committee.

More... »


CWWeekly

May 18

Research for All Act reaches Congress for second time seeking gender equality in basic research, clinical trials

MediciGlobal finds fewer trial dropouts among participants who actively pursue enrollment versus those recruited

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs